Found 23 matching trials
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes
PHASE3This study is being done to find out the good and bad effects of a drug tha...
Location
Pfizer Investigational Site
Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder
N/AThe purpose of this study is to allow patients with specific needs for inha...
Status
No Longer Available
Location
Endocrinology Associates
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
PHASE4The primary objective of this study is to assess whether a simple initial d...
Location
Pfizer Investigational Site
Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.
PHASE3To assess the impact on glucose control by inhaled insulin alone or added t...
Location
Pfizer Investigational Site
Follow-Up Study for Exubera
N/AIn studies of Exubera in persons with diabetes, lung cancer occurred in a f...
Location
Pfizer Investigational Site
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
PHASE4The purpose of this study is to evaluate the long-term pulmonary and cardio...
Location
Pfizer Investigational Site
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
PHASE4This study is to determine if inhaled insulin is effective in treating type...
Location
Pfizer Investigational Site
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
PHASE3To assess the impact on glucose control by inhaled insulin in patients with...
Location
Pfizer Investigational Site
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
PHASE3This study is being done to find out the good and bad effects of inhaled in...
Location
Pfizer Investigational Site
Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
PHASE3Assess the safety and toleration of CP-464,005 and Inhaler following 1-year...
Location
Pfizer Investigational Site